$27.69
0.130.47%
Last update: 5:40 PM
15 minutes delayed
Comments
Loading...
Omnicell
OMCLNASDAQ
want to know what
the Bulls & Bears Say?
Omnicell (NASDAQ:OMCL) Stock, Analyst Ratings, Price Targets, Forecasts
Omnicell Inc has a consensus price target of $76.13 based on the ratings of 10 analysts. The high is $205 issued by Craig-Hallum on November 3, 2021. The low is $26 issued by Wells Fargo on February 9, 2024. The 3 most-recent analyst ratings were released by Benchmark on July 15, 2024, May 3, 2024, and April 30, 2024, respectively. With an average price target of $38 between Benchmark, there's an implied 34.54% upside for Omnicell Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Benchmark
Wells Fargo
Piper Sandler
Piper Sandler
JP Morgan
1calculated from analyst ratings
Analyst Ratings for Omnicell
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/15/2024 | Buy Now | 34.54% | Benchmark | Bill Sutherland | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2024 | Buy Now | 34.54% | Benchmark | Bill Sutherland | → $38 | Reiterates | Buy → Buy | Get Alert |
| 04/30/2024 | Buy Now | 34.54% | Benchmark | Bill Sutherland | → $38 | Reiterates | Buy → Buy | Get Alert |
| 02/09/2024 | Buy Now | 34.54% | Benchmark | Bill Sutherland | $42 → $38 | Maintains | Buy | Get Alert |
| 02/09/2024 | Buy Now | -7.95% | Wells Fargo | Stan Berenshteyn | $28 → $26 | Maintains | Equal-Weight | Get Alert |
| 11/03/2023 | Buy Now | -0.87% | Wells Fargo | Stan Berenshteyn | $39 → $28 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 11/03/2023 | Buy Now | — | BTIG | David Larsen | — | Downgrade | Buy → Neutral | Get Alert |
| 11/03/2023 | Buy Now | 38.08% | Piper Sandler | Sean Wieland | $70 → $39 | Upgrade | Neutral → Overweight | Get Alert |
| 10/11/2023 | Buy Now | — | Keybanc | Scott Schoenhaus | — | Downgrade | Overweight → Sector Weight | Get Alert |
| 10/03/2023 | Buy Now | 147.83% | Benchmark | Bill Sutherland | $88 → $70 | Maintains | Buy | Get Alert |
| 09/26/2023 | Buy Now | 38.08% | Wells Fargo | Stan Berenshteyn | $56 → $39 | Maintains | Underweight | Get Alert |
| 08/04/2023 | Buy Now | 165.53% | Keybanc | Scott Schoenhaus | $80 → $75 | Maintains | Overweight | Get Alert |
| 08/02/2023 | Buy Now | 211.56% | Benchmark | Bill Sutherland | → $88 | Reiterates | Buy → Buy | Get Alert |
| 08/02/2023 | Buy Now | 147.83% | Piper Sandler | Jessica Tassan | $66 → $70 | Downgrade | Overweight → Neutral | Get Alert |
| 07/31/2023 | Buy Now | 211.56% | Benchmark | Bill Sutherland | → $88 | Reiterates | Buy → Buy | Get Alert |
| 07/20/2023 | Buy Now | 98.27% | Wells Fargo | Stan Berenshteyn | $65 → $56 | Downgrade | Overweight → Underweight | Get Alert |
| 07/13/2023 | Buy Now | 183.24% | Keybanc | Scott Schoenhaus | $70 → $80 | Maintains | Overweight | Get Alert |
| 06/15/2023 | Buy Now | 211.56% | Benchmark | Bill Sutherland | $68 → $88 | Maintains | Buy | Get Alert |
| 05/03/2023 | Buy Now | 147.83% | Keybanc | Scott Schoenhaus | $65 → $70 | Maintains | Overweight | Get Alert |
| 03/02/2023 | Buy Now | 130.13% | Keybanc | Scott Schoenhaus | $70 → $65 | Maintains | Overweight | Get Alert |
| 03/01/2023 | Buy Now | 140.75% | Benchmark | Bill Sutherland | → $68 | Reiterates | → Buy | Get Alert |
| 02/27/2023 | Buy Now | 140.75% | Benchmark | Bill Sutherland | → $68 | Upgrade | Hold → Buy | Get Alert |
| 02/02/2023 | Buy Now | 147.83% | Keybanc | Scott Schoenhaus | $75 → $70 | Maintains | Overweight | Get Alert |
| 01/27/2023 | Buy Now | 133.67% | Piper Sandler | Jessica Tassan | $55 → $66 | Maintains | Overweight | Get Alert |
| 01/24/2023 | Buy Now | 130.13% | Wells Fargo | Stan Berenshteyn | $71 → $65 | Maintains | Overweight | Get Alert |
| 11/18/2022 | Buy Now | 101.81% | JP Morgan | Anne Samuel | $140 → $57 | Maintains | Neutral | Get Alert |
| 11/04/2022 | Buy Now | 151.37% | Wells Fargo | Stan Berenshteyn | $158 → $71 | Maintains | Overweight | Get Alert |
| 11/03/2022 | Buy Now | 165.53% | BTIG | David Larsen | $160 → $75 | Maintains | Buy | Get Alert |
| 11/03/2022 | Buy Now | — | Benchmark | Bill Sutherland | — | Downgrade | Buy → Hold | Get Alert |
| 11/03/2022 | Buy Now | 91.18% | SVB Leerink | Joy Zhang | $117 → $54 | Maintains | Market Perform | Get Alert |
| 11/03/2022 | Buy Now | 165.53% | Keybanc | Scott Schoenhaus | $130 → $75 | Maintains | Overweight | Get Alert |
| 09/23/2022 | Buy Now | 455.85% | Benchmark | Bill Sutherland | $170 → $157 | Maintains | Buy | Get Alert |
| 09/21/2022 | Buy Now | 466.47% | BTIG | David Larsen | $175 → $160 | Maintains | Buy | Get Alert |
| 09/21/2022 | Buy Now | 413.37% | Piper Sandler | Jessica Tassan | $150 → $145 | Maintains | Overweight | Get Alert |
| 09/16/2022 | Buy Now | 360.26% | Keybanc | Scott Schoenhaus | → $130 | Initiates | → Overweight | Get Alert |
| 09/09/2022 | Buy Now | 324.85% | B of A Securities | Allen Lutz | → $120 | Initiates | → Buy | Get Alert |
| 08/08/2022 | Buy Now | 431.07% | Piper Sandler | Jessica Tassan | $162 → $150 | Maintains | Overweight | Get Alert |
| 07/27/2022 | Buy Now | 519.58% | BTIG | David Larsen | $190 → $175 | Maintains | Buy | Get Alert |
| 07/15/2022 | Buy Now | 339.02% | SVB Leerink | Joy Zhang | → $124 | Initiates | → Market Perform | Get Alert |
| 05/03/2022 | Buy Now | 459.39% | Wells Fargo | Stan Berenshteyn | $188 → $158 | Maintains | Overweight | Get Alert |
| 05/03/2022 | Buy Now | 473.55% | Piper Sandler | Sean Wieland | $181 → $162 | Maintains | Overweight | Get Alert |
| 02/16/2022 | Buy Now | 565.6% | Wells Fargo | Stan Berenshteyn | $203 → $188 | Maintains | Overweight | Get Alert |
| 12/06/2021 | Buy Now | 618.71% | Wells Fargo | Stan Berenshteyn | — | Initiates | → Overweight | Get Alert |
| 12/01/2021 | Buy Now | 678.9% | BTIG | David Larsen | — | Maintains | Buy | Get Alert |
| 11/03/2021 | Buy Now | 625.79% | Craig-Hallum | Matt Hewitt | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Omnicell (OMCL) stock?
The latest price target for Omnicell (NASDAQ:OMCL) was reported by Benchmark on July 15, 2024. The analyst firm set a price target for $38.00 expecting OMCL to rise to within 12 months (a possible 37.23% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Omnicell (OMCL)?
The latest analyst rating for Omnicell (NASDAQ:OMCL) was provided by Benchmark, and Omnicell reiterated their buy rating.
When was the last upgrade for Omnicell (OMCL)?
The last upgrade for Omnicell Inc happened on November 3, 2023 when Wells Fargo raised their price target to $28. Wells Fargo previously had an underweight for Omnicell Inc.
When was the last downgrade for Omnicell (OMCL)?
The last downgrade for Omnicell Inc happened on November 3, 2023 when BTIG changed their price target from N/A to N/A for Omnicell Inc.
When is the next analyst rating going to be posted or updated for Omnicell (OMCL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Omnicell, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Omnicell was filed on July 15, 2024 so you should expect the next rating to be made available sometime around July 15, 2025.
Is the Analyst Rating Omnicell (OMCL) correct?
While ratings are subjective and will change, the latest Omnicell (OMCL) rating was a reiterated with a price target of $38.00 to $38.00. The current price Omnicell (OMCL) is trading at is $27.69, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.